Evidence map›Paper›PMID 36859311›Full record

ReviewJournal of nanobiotechnology2023

Roles of MXenes in biomedical applications: recent developments and prospects.

Hui Li, Rangrang Fan, Bingwen Zou, Jiazhen Yan, Qiwu Shi, Gang Guo

Abstract readReview
In one paragraph

Review in Journal of nanobiotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Review
  2. MXene Bioinks for 3D Bioprinting: Design and Translation.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  3. Article
  4. TiACS applied materials & interfaces · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Beyond graphene: the MXene era in bioprinting.Biomedical engineering online · 2026
    Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. MXene and prostate cancer: is there promising news?Nanomedicine (London, England) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hui LiState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Rangrang FanState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Bingwen ZouState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
Jiazhen YanSchool of Mechanical Engineering, Sichuan University, Chengdu, 610065, China.
Qiwu ShiCollege of Materials Science and Engineering, Sichuan University, Chengdu, 610065, Sichuan, China.
Gang GuoState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China. guogang@scu.edu.cn.

Funding

National Natural Sciences Foundation of China 31971308
6 · The paper itself

Abstract

....With the development of nanomedical technology, the application of various novel nanomaterials in the biomedical field has been greatly developed in recent years. MXenes, which are new inorganic nanomaterials with ultrathin atomic thickness, consist of layered transition metal carbides and nitrides or carbonitrides and have the general structural formula M

Indexed as

NanostructuresWearable Electronic DevicesAnti-Bacterial AgentsImmunotherapyNitritesTransition ElementsAnti-Bacterial AgentsMXeneNitritesTransition ElementsBiosensorsDiagnosisImmunotherapyMXenesSynthesisWearable device

Identifiers

PMID36859311
PMCPMC9979438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.